Table 1.
General characteristics of study group (n = 1613).
| Demographics | Number (%) or Mean (±SD) | ||
| Women | 705 (44) | ||
| Age (years) | 71.98 (±11.61) | ||
| BMI (kg/m2) | 29.35 (±5.60) | ||
| SUA < 5 mg/dL | 233 (14) | ||
| SUA > 7 mg/dL | 695 (43) | ||
| High cardiovascular risk * | 1362 (84) | ||
| Comorbidities | Number (%) | ||
| Arterial hypertension | 1343 (83) | ||
| Heart failure | 1087 (67) | ||
| HFrEF (EF < 40%) | 300 (19) | ||
| Diabetes | 539 (33) | ||
| History of stroke | 190 (12) | ||
| History of TIA | 95 (6) | ||
| CAD | 806 (50) | ||
| Post CABG | 121 (7.5) | ||
| Post PCI | 365 (23) | ||
| History of MI | 355 (22) | ||
| PAD | 232 (14) | ||
| CKD (MDRD < 60) | 812 (50) | ||
| Laboratory Results (unit) | Mean | Standard Deviation | |
| HGB (g/dL) | 13.25 | 1.88 | |
| GFR (mL/min/1.73 m2) | 62.24 | 22.12 | |
| ALT (U/L) | 31.05 | 52.03 | |
| AST (U/L) | 33.48 | 50.10 | |
| SUA (mg/dL) | 6.88 | 1.93 | |
| TC (mg/dL) | 167.47 | 52.40 | |
| LDL (mg/dL) | 97.93 | 43.67 | |
| HDL (mg/dL) | 47.60 | 22.12 | |
| TG (mg/dL) | 124.88 | 61.75 | |
| EF (%) | 48.84 | 13.34 | |
Abbreviations: BMI, body mass index; HGB, hemoglobin; GFR, glomerular filtration rate; ALT, alanine aminotransferase; AST, aspartate aminotransferase; SUA, serum uric acid; TC, total cholesterol; LDL, low-density lipoproteins; HDL, high-density lipoproteins; TG, triglycerides; EF, ejection fraction; HFrEF, heart failure with reduced ejection fraction; TIA, transient ischemic attack; CAD, coronary arterial disease; CABG, coronary-aortic bypass graft; PCI, percutaneous coronary intervention; MI, myocardial infarction; PAD, peripheral arterial disease; CKD, chronic kidney disease. * High cardiovascular risk defined as in Borghi et al. and described in the Materials and Methods section [4,5].